Sepsis studies need new direction

被引：126

作者：

Cohen, Jonathan ^{[1
]}

Opal, Steven ^{[2
]}

Calandra, Thierry

机构：

[1] Univ Brighton, Brighton & Sussex Med Sch, Brighton BN1 9PH, E Sussex, England

[2] Brown Univ, Providence, RI 02912 USA

来源：

LANCET INFECTIOUS DISEASES | 2012年 / 12卷 / 07期

关键词：

SEPTIC SHOCK; DEFINITION; EFFICACY; SAFETY;

D O I：

10.1016/S1473-3099(12)70136-6

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：503 / 505

页数：3

共 8 条

[1] Improving clinical trials in the critically ill: Unique challenge-Sepsis [J].

Annane, Djillali .

CRITICAL CARE MEDICINE, 2009, 37 (01) :S117-S128

[2] Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].

Bernard, GR ;

Vincent, JL ;

Laterre, P ;

LaRosa, SP ;

Dhainaut, JF ;

Lopez-Rodriguez, A ;

Steingrub, JS ;

Garber, GE ;

Helterbrand, JD ;

Ely, EW ;

Fisher, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709

[3] Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: Results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial [J].

Dellinger, R. Phillip ;

Tomayko, John F. ;

Angus, Derek C. ;

Opal, Steven ;

Cupo, Michael A. ;

McDermott, Sharon ;

Ducher, Annie ;

Calandra, Thierry ;

Cohen, Jonathan .

CRITICAL CARE MEDICINE, 2009, 37 (11) :2929-2938

[4] Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria [J].

Klouwenberg, Peter M. C. Klein ;

Ong, David S. Y. ;

Bonten, Marc J. M. ;

Cremer, Olaf L. .

INTENSIVE CARE MEDICINE, 2012, 38 (05) :811-819

[5] Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88:: Effect on survival in patients with septic shock [J].

López, A ;

Lorente, JA ;

Steingrub, J ;

Bakker, J ;

McLuckie, A ;

Willatts, S ;

Brockway, M ;

Anzueto, A ;

Holzapfel, L ;

Breen, D ;

Silverman, MS ;

Takala, J ;

Donaldson, J ;

Arneson, C ;

Grove, G ;

Grossman, S ;

Grover, R .

CRITICAL CARE MEDICINE, 2004, 32 (01) :21-30

[6]

Matsuyama K, EISAIS SEPSIS DRUG E

[7] A genomic storm in critically injured humans [J].

Xiao, Wenzhong ;

Mindrinos, Michael N. ;

Seok, Junhee ;

Cuschieri, Joseph ;

Cuenca, Alex G. ;

Gao, Hong ;

Hayden, Douglas L. ;

Hennessy, Laura ;

Moore, Ernest E. ;

Minei, Joseph P. ;

Bankey, Paul E. ;

Johnson, Jeffrey L. ;

Sperry, Jason ;

Nathens, Avery B. ;

Billiar, Timothy R. ;

West, Michael A. ;

Brownstein, Bernard H. ;

Mason, Philip H. ;

Baker, Henry V. ;

Finnerty, Celeste C. ;

Jeschke, Marc G. ;

Lopez, M. Cecilia ;

Klein, Matthew B. ;

Gamelli, Richard L. ;

Gibran, Nicole S. ;

Arnoldo, Brett ;

Xu, Weihong ;

Zhang, Yuping ;

Calvano, Steven E. ;

McDonald-Smith, Grace P. ;

Schoenfeld, David A. ;

Storey, John D. ;

Cobb, J. Perren ;

Warren, H. Shaw ;

Moldawer, Lyle L. ;

Herndon, David N. ;

Lowry, Stephen F. ;

Maier, Ronald V. ;

Davis, Ronald W. ;

Tompkins, Ronald G. .

JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (13) :2581-2590

[8] An evaluation of the diagnostic accuracy of the 1991 American College of Chest Physicians/Society of Critical Care Medicine and the 2001 Society of Critical Care Medicine/European Society of Intensive Care Medicine/American College of Chest Physicians/American Thoracic Society/Surgical Infection Society sepsis definition [J].

Zhao, Huifang ;

Heard, Stephen O. ;

Mullen, Marie T. ;

Crawford, Sybil ;

Goldberg, Robert J. ;

Frendl, Gyorgy ;

Lilly, Craig M. .

CRITICAL CARE MEDICINE, 2012, 40 (06) :1700-1706

← 1 →